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Abstract
In order to better understand the cause of hereditary hearing impairment, we have performed a proteomic analysis of the
inner ear proteins using two-dimensional gel electrophoresis. In the process of analysis, we have found very unique properties
of the bovine homologue of the human COCH gene product. The COCH gene is responsible for one of the hereditary hearing
impairments, DFNA9, and was recently suggested to be a possible genetic factor contributing to Me¤nie're’s disease. The Coch
protein constitutes 70% of bovine inner ear proteins and is composed of 16 different protein spots, with charge and size
heterogeneity. Heterogeneity of this protein suggests that the Coch gene is processed in several ways, at the transcriptional
and/or posttranslational level. Much knowledge has accumulated about the hereditary hearing impairment genes; however,
little research has been done regarding the protein products of those genes. This is the first report to characterize the Coch
protein. Study of the Coch protein might provide more information on the mechanism of hearing and vestibular
disorders. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
In recent years, due to the technological advances
of molecular biology, many important ¢ndings are
reported in the ¢eld of hereditary hearing impair-
ment (HHI). Some of the HHI genes are cloned and
the mutations of those genes are identi¢ed [1]. To
date, 28 loci for autosomal dominant (pre¢x
DFNA) and 26 loci for autosomal recessive (pre¢x
DFNB) non-syndromic hearing impairment are
known. Much knowledge has accumulated about
the HHI genes; however, little research has been
done regarding the protein products of those genes.
In order to characterize deafness genes at the protein
level as well as other inner ear proteins, we have
performed a proteomic analysis of the inner ear pro-
teins. In the process of analysis, we have found very
unique properties of the protein product of a deaf-
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ness gene, COCH (also known as Coch-5B2). The
COCH gene is responsible for one of the HHI,
DFNA9. DFNA9 is the locus in humans reported
to involve vestibular problems as part of the non-
syndromic deafness phenotype. The primary patho-
logic change of the DFNA9 is a deposit of acid poly-
mucosaccharide ground substance in the cribrous
areas, in the spiral ligament, limbus, and spiral lam-
ina of the cochlea, and in the stroma of the maculae
and cristae. The end result is neuronal degeneration
in association with varying degrees of atrophic
change in the sense organs [2]. Recently, it has
been suggested that missense mutation in the
COCH gene might be related to the pathogenesis
of Me¤nie're’s disease [3].
Our results show that the protein product of the
Coch gene constitutes 70% of inner ear proteins and
is composed of 16 di¡erent protein spots with charge
and size heterogeneity. Heterogeneity of this protein
suggests that the Coch gene is processed in several
ways and may suggest that the Coch protein is very
important in the inner ear function.
2. Materials and methods
2.1. Bovine inner ear tissue sample preparation
The adult bovine cochlear and vestibular membra-
nous labyrinthine tissues were dissected out from bo-
vine temporal bones. The tissues were homogenized
with 20 vols. of solubilization mixture containing 7 M
urea, 2 M thiourea, 2% Triton X-100, 1% Pharma-
lyte, 100 mM dithiothreitol (DTT) and antiprotease
mixture (Complete mini EDTA(3), Boehringer
Mannheim, Mannheim, Germany).
2.2. Two-dimensional gel electrophoresis (2D-GE)
2D-GE was performed according to the manufac-
turer’s protocol for the immobilized pH gradient gel
(Immobiline pH 3^10, Amersham Pharmacia Bio-
tech, Buckinghamshire, UK). For each electropho-
retic run, Immobiline Dry Strips were rehydrated
with a solution consisting of 7 M urea, 2 M thiourea,
2% Triton X-100, 1% Pharmalyte and 100 mM
DTT. First dimension electrophoresis was done by
an electrofocusing apparatus, MultiphorII (Amer-
sham Pharmacia Biotech). One hundred microliters
of the samples were loaded at the anode end. Elec-
trofocusing was carried out with 300 V for 60 s
followed by a gradient increase from 300 to 3500 V
in 90 min and constant 3500 V for 18 h. After the
¢rst dimensional electrophoresis, each gel strip was
equilibrated in a solution consisting of 7 M urea,
25% of glycerol, 50 mM Tris-HCl (pH 6.8), 2%
SDS, 33 mM DTT with 1.6% bromophenol blue
for 40 min. The second dimensional electrophoresis
was performed using 3% stacking and 12% separat-
ing polyacrylamide gel (14U10 cm with 1 mm thick-
ness) containing 0.1% SDS with a running bu¡er
(25 mM Tris base, 192 mM glycine, 0.1% SDS) at
20 mA for 5 h.
2.3. N-Terminal and internal amino acid (AA)
sequence analysis of proteins
Internal AA sequences were analyzed according to
Aebersold et al. with minor modi¢cations [4,5]. Gels
were blotted onto a PVDF membrane (ProBlott, Ap-
plied Biosystems, Foster City, CA, USA) with a
transfer bu¡er (25 mM Tris, 192 mM glycine, 0.1%
SDS, 10% methanol) at 120 mA for 90 min. Proteins
on the membrane were stained with Coomassie bril-
liant blue R-250 (CBB) and visualized. Protein spots
were excised and then subjected to N-terminal
AA sequencing with a 492 cLC pulse-liquid phase
sequencer (Applied Biosystems) [6]. Alternatively,
the membrane bound protein was subjected to in
situ proteolytic cleavage with lysyl endopeptidase
AP-1 (Lys-C, Wako Pure Chemical Industries,
Osaka, Japan) at 2 Wg/ml in a digestion bu¡er
(20 mM Tris-HCl at pH 8.5, 8% acetonitrile). The
resulting peptides were separated with an HPLC ap-
paratus, Model 172 (Applied Biosystems), and se-
quenced. The AA sequences were compared with
the international sequence database, GENETYX
(Software Development, Tokyo, Japan) and BLAST
(NCBI).
2.4. Analysis of gel images
The primary image of the representative 2D-GE of
inner ear protein was processed with ImageMaster
2D Elite software (Amersham Pharmacia Biotech).
Individually resolved protein features stained with
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CBB were enumerated and quanti¢ed on the basis of
signal intensity. The indexes (normalized volume (the
ratio of the proteins to total protein in the gel), iso-
electric point (pH), relative molecular mass (kDa)) of
each feature were calculated by the ImageMaster sys-
tem formally calibrated with respect to a two-dimen-
sional size marker, 2D SDS-PAGE standards (Bio-
Rad, Hercules, CA, USA).
2.5. In-gel digestion of proteins for determining
a peptide map
A peptide map of proteins was obtained using the
Cleveland method with a few modi¢cations to get
sharp peptide pro¢les [7,8]. A protease pre-electro-
phoresed slab gel was prepared beforehand as fol-
lows. Lys-C (1 Wg) dissolved in a stacking gel bu¡er
(125 mM Tris-HCl, pH 6.8, 1 mM EDTA, 0.1%
SDS, 10% glycerol) was put in a well of a 5% stack-
ing and 15% separating polyacrylamide gel (9 cmU
9 cmU0.2 cm). Pre-electrophoresis was performed at
40 mA for 10 min, and Lys-C was run into the stack-
ing gel layer. A protein spot that contained a target
protein was cut out from a two-dimensional gel and
equilibrated with the sample bu¡er (125 mM Tris-
HCl, pH 6.8, 1 mM EDTA, 1.5 mM DTT, 0.1%
SDS, 10% sucrose) for 30 min at room temperature
with gentle shaking. Each gel piece was put into the
well. The target protein was then electroeluted at 20
mA into the stacking gel containing Lys-C. Electro-
phoresis was temporarily paused for 30 min to allow
the Lys-C to digest the target protein into peptide
fragments. Those peptide fragments and protease
were then electrophoresed at 40 mA for 1 h in a
15% separating gel to form a peptide map and the
protease band. Peptides were visualized by silver
staining using Silver Stain II (Daiich Pure Chemicals,
Tokyo, Japan).
3. Results
3.1. The pattern of 2D-GE of inner ear proteins
Bovine inner ear protein was subjected to 2D-GE.
The gel was stained with CBB. The representative
image is shown in Fig. 1a and the boxed area is
enlarged in Fig. 1b.
3.2. N-Terminal AA sequences
Major protein spots in this 2D-GE analysis were
subjected to N-terminal AA sequencing. Among
those spots, sequence data of 16 major spots had
high homology to the AA sequences deduced from
human COCH cDNA (Table 1). These spots were
selected and designated as p63-1 to p63-8 (p63s),
p44-1 to p44-5 (p44s) and p40-1 to p40-3 (p40s)
from alkaline to acidic direction as shown in Fig.
Fig. 1. (a) 2D-GE analysis of bovine inner ear protein (CBB
staining). Protein spots: 1, BSA; 2, K-tubulin; 3, L-tubulin;
4, OCP-2. (b) Enlarged image of the boxed area of the 2D gel
in panel a. The Coch proteins are designated as p63-1 to p63-8,
p44-1 to p44-5 and p40-1 to p40-3 from alkaline to acidic direc-
tion.
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1b. These three lines of proteins, composed of eight,
¢ve, and three protein spots with di¡erent isoelectric
points, possessed di¡erent amino terminus sequences.
The amino terminus of p63s, p44s, p40s start from
the 25th, 133rd and 152nd AA of the COCH se-
quence, respectively (Table 1, Fig. 4). Partial amino
terminal sequences of p63s, p44s and p40s showed
83%, 95% and 97% identity with COCH, respec-
tively. In total, 74 out of 81 AAs (91%) in the amino
terminus of 16 independent proteins were identical
with COCH. No other sequenced spots in the two-
dimensional gel were homologous to COCH. Other
protein spots such as bovine serum albumin (BSA),
K- and L-tubulin, and OCP-2 (organ of corti protein
2) are also shown in Fig. 1a (protein spots numbered
as 1, 2, 3, 4, respectively). The report of all other
identi¢ed protein spots is under preparation.
3.3. The internal AA sequences
To identify the internal AA sequences, p63-1, p44-
1 and p40-1 were subjected to in situ proteolytic
cleavage and separated with HPLC (Fig. 2). The
numbered peptide peaks of HPLC pro¢les were se-
quenced. As shown in Table 2 and Fig. 4, peptide
peaks Nos. 2, 5 and 7 have identical sequences cor-
responding to the sequence from the 234th to 246th
Fig. 2. HPLC pro¢les of the peptides released by in situ pro-
tease (Lys-C) digestion of proteins p63-1, p44-1 and p40-1. The
bottom line corresponds to the control membrane where no
protein spot is detected. Column: reverse-phase C8 column
(Aquapore RP-300, 1 mmU100 mm, Applied Biosystems). Sol-
vent: linear gradient from 0^70% acetonitrile in 0.1% TFA.
Monitoring: absorbance at 215 nm (intensity is not scaled). Se-
quenced peaks were numbered from 1 to 8.
Table 1
Bovine Coch N-terminal AA sequences and comparison with the AA sequences deduced from human, mouse, and chicken Coch
cDNA
* indicates AA which is not determined (in the Edman degradation method, cysteine residues cannot be determined de¢nitely), and ^
indicates common sequence with human.
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AA of COCH. Peptide peaks Nos. 3, 6, 8 show iden-
tical sequences and correspond to the sequence from
the 255th to 264th AA of COCH. These sequences
have 92% and 70% homology with the COCH se-
quence, respectively. In total, as shown in Table 2,
42 out of 49 AAs (86%) in eight independent pep-
tides were identical with COCH.
From the N-terminal and internal AA sequence
analysis it is suggested that p63s, p44s and p40s are
closely related protein products of the COCH gene.
3.4. Gel image analysis of the Coch proteins
The representative CBB stained gel was analyzed
by ImageMaster 2D Elite software. As shown in Ta-
ble 3, the summed volume of p63s is 32.2%, of p44s
is 12.9% and of p40s is 25.3%. In total, 70.4% of all
inner ear proteins were composed of the Coch pro-
teins.
There is a tendency that the spots with a higher
isoelectric point migrate slightly faster than the acidic
Fig. 3. Peptide maps by in-gel digestion with Lys-C of p63-1 to 6, p44-1 to 5 and p40-1 to 3. In each set of gel electrophoresis, the
well marked # is a molecular size marker and the well marked * is Lys-C without protein sample.
Table 2
Bovine internal AA sequence of Coch proteins and comparison with AA sequences deduced from human, mouse, and chicken Coch
cDNA
The numbered peptide peaks of the HPLC pro¢le (Fig. 2) were subjected to sequencing.
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ones in secondary SDS-PAGE. The molecular mass
of p63-1 is 63 kDa, whereas that of p63-8 is 66 kDa.
The same tendency was also observed in p44s and
p40s. The range of isoelectric points was from 6.1 to
7.4 in p63s, from 6.2 to 7.1 in p44s and from 5.8 to
6.1 in p40s.
3.5. In-gel digestion for a peptide map
To further identify these Coch proteins, p63-1 to
p63-6, p44-1 to p44-5 and p40-1 to p40-3 were sub-
jected to in-gel digestion to determine the peptide
maps (Fig. 3). The peptide maps showed high sim-
ilarity among p63-1 to p63-6, p44-1 to p44-5 and
p40-1 to p40-3. It is highly possible that each series
of proteins, p63s, p44s and p40s, possess an identical
primary structure. The di¡erences in isoelectric
points are most probably due to posttranslational
modi¢cations.
4. Discussion
Robertson et al. [9,10] undertook subtractive hy-
bridization and di¡erential screening to isolate genes
expressed in the human cochlea for candidate genes
in deafness disorders. They constructed a human fe-
tal cochlea cDNA library and isolated a novel co-
chlear gene, COCH.
They showed that COCH is highly conserved in
human, mouse, and chicken, showing 94% and 79%
amino acid identity of human to mouse and chicken
sequences, respectively [11]. In this paper, the bovine
sequence was shown to be also highly conserved. In
total, 92 out of 103 amino acids (89.3%) are identical
to the human sequence. The function of COCH is
unknown but several characteristics of the protein
point to a structural role in the extracellular matrix
[10]. The fact that the Coch protein constitutes 70%
Fig. 4. Schematic representation of the COCH gene and protein. The top line demonstrates the deduced amino acid sequence of hu-
man COCH, showing the positions of cysteine residues (vertical bar ‘I’) with respect to von Willebrand factor type A (vWF A)-like
domains. The bottom lines depict the bovine Coch proteins p63, p44 and p40. Black bar, amino termini ; dashed bar, internal sequen-
ces and number of peptide peaks (Fig. 2) in brackets; vertical arrow, mutation sites in DFNA9.
Table 3
Gel image analysis of Coch proteins. Calculated indexes (nor-
malized volume (the ratio of the Coch proteins to total protein
in the gel), isoelectric point (pI), relative molecular mass (kDa))
are shown. Summed volume of p63s is 32.2%, of p44s is 12.9%
and p40s is 25.3%. In total, 70.4% of all inner ear proteins
were composed of Coch proteins
Protein Norm. vol.% pI Mol. mass (kDa)
p63-1 1.7 7.4 63.0
p63-2 6.9 7.2 63.4
p63-3 9.8 7.0 64.0
p63-4 6.6 6.8 64.2
p63-5 4.6 6.6 65.0
p63-6 2.2 6.4 65.7
p63-7 0.4 6.3 65.9
p63-8 0.1 6.1 65.9
32.2 (p63s subtotal %)
p44-1 3.9 7.1 43.8
p44-2 2.4 6.9 45.2
p44-3 4.6 6.6 45.5
p44-4 1.8 6.4 45.9
p44-5 0.2 6.2 46.6
12.9 (p44s subtotal %)
p40-1 20.2 6.1 40.1
p40-2 3.9 6.0 40.6
p40-3 1.2 5.8 41.5
25.3 (p40s subtotal %)
70.4 (total %)
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of all inner ear proteins may also support this hy-
pothesis. Other abundant proteins in the inner ear
such as collagen type II [12] were not detected in
our proteomic analysis. One of the hallmarks of col-
lagen is its resistance to solubilization using urea [13].
Solubility of the protein product of Coch under these
experimental conditions is di¡erent from that of the
collagens. As a result, the Coch protein is the most
predominant component of the inner ear proteins in
2D-GE.
From the 2D-GE, the Coch proteins showed
charge and size heterogeneity. Transcriptional and/
or posttranslational modi¢cations should be respon-
sible for this heterogeneity. Northern blot analysis
showed that the COCH gene has three messages ap-
prox. 2.0, 2.3 and 2.9 kb in size in the human cochlea
[10]. Robertson et al. discussed that the majority of
isolated cDNAs possess the ¢rst polyadenylation site,
corresponding to the middle sized and the most pre-
dominant (highest level) of the three COCH tran-
scripts. The smallest COCH mRNA would be the
result of usage of a di¡erent (more 5P) polyadenyla-
tion site, or may be a product of alternative splicing,
exon skipping, or di¡erential use of promoter cap
sites. These transcriptional modi¢cations might lead
to the expression of the Coch proteins as di¡erent
molecular weight proteins.
Our results showed that the amino termini of p63s
start from the 25th AA of COCH. This should be the
result of cleaving the leader peptide, the most amino-
terminal portion of the COCH protein that is pre-
dicted to be the signal peptide [10].
Four COCH mutations are reported so far, Pro51
to Ser [3,14], Val66 to Gly, Gly88 to Glu, and
Trp117 to Arg [11]. Amino acid changes in this cys-
teine containing region may interfere with the forma-
tion of disul¢de bonds, disrupting proper folding and
the overall structure of the protein. Altered tertiary
structure may perturb function. The p44s and the
p40s do not contain any of these reported mutation
sites (Fig. 4). The study of these processed Coch
proteins is important to understand how these muta-
tions really a¡ect the function of this protein.
Based upon the N-terminal sequences, the di¡er-
ence in molecular mass between p63s and p44s (25th
to 132nd AA of COCH) is calculated to be 11 360
Da, and that between p44s and p40s (133rd to 151st
AA of COCH) is 1948 Da. These di¡erences are
smaller than those predicted from their mobilities
in gel electrophoresis. Moreover, the isoelectric
points of p63s, p44s and p40s range from 6.1 to
7.4, from 6.2 to 7.1 and from 5.8 to 6.1, respectively.
These results indicate that other posttranslational
modi¢cations should be involved in the di¡erence
in molecular mass and isoelectric point of these pro-
teins. These may include: (1) proteolysis at the pep-
tide bond removing other intervening or C-terminal
sequences as for intracellular processing, (2) action of
proteolytic cascades in the metabolism of secreted
molecules, (3) chemical modi¢cation such as glyco-
sylation, phosphorylation and/or deamination [15].
Alternatively, this heterogeneity could be due to the
conformational isomers as shown in major histocom-
patibility class II K and L polypeptide chains [16].
The heterogeneity in charge and size of the Coch
protein indicated that the Coch protein is possibly
highly modi¢ed in the inner ear. It is possible that
altered modi¢cation of this protein might lead to
functional disturbance in the inner ear. In the case
of Alzheimer’s disease, abnormal phosphorylation of
tau is found in paired helical ¢laments, which is the
characteristic pathological ¢nding in the patient’s
brain [17,18].
Thalman et al. did a pioneering work in the 2D-
GE of inner ear protein. They reported the analysis
of inner ear tissue and liquids, and identi¢ed inner
ear speci¢c proteins, OCP-1 and -2 [19,20]. The pat-
tern of 2D-GE of inner ear tissue (organ of corti) is
quite di¡erent from our results, probably due to the
di¡erence in several experimental conditions. First,
we have used bovine inner ear tissue including both
cochlear and vestibular labyrinths, and second, thio-
urea is utilized for solubilization of inner ear tissue
and rehydration of gel strips. It is known that thio-
urea is important to increase the solubility of pro-
teins [21].
This is the ¢rst report to characterize deafness
gene expression at the protein level in 2D-GE. The
study of deafness genes at the protein level might
give us more information about the mechanism of
hearing and vestibular disorders.
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